AstraZeneca launches heart drug in India Business Standard AstraZeneca Pharma India today launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval from the Drug Controller General of India (DCGI). Based on the New Drug Advisory Committee's (NDAC) recommendations, ... |
